Phase II Study Assessing the Efficacy and Safety of Lenvatinib for Anaplastic Thyroid Cancer

Condition:   Anaplastic Thyroid Cancer
Intervention:   Drug: Lenvatinib
Sponsor:   Translational Research Informatics Center, Kobe, Hyogo, Japan
Recruiting - verified March 2016

from #ORL via xlomafota13 on Inoreader http://ift.tt/1MZDD3T
via IFTTT